# Variability in the Measurement of WBCT Between Blood Drawn From Indwelling Catheters and Direct Venipuncture

> **NCT02207205** · NA · COMPLETED · sponsor: **Perosphere Pharmaceuticals Inc, a wholly owned subsidiary of AMAG Pharmaceuticals, Inc.** · enrollment: 10 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Blood drawn from indwelling catheters versus direct venipuncture

## Key facts

- **NCT ID:** NCT02207205
- **Lead sponsor:** Perosphere Pharmaceuticals Inc, a wholly owned subsidiary of AMAG Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-04
- **Primary completion:** 2014-05
- **Final completion:** 2014-06
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2018-04-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02207205

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02207205, "Variability in the Measurement of WBCT Between Blood Drawn From Indwelling Catheters and Direct Venipuncture". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02207205. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*